COVID-19 and family violence: A rapid review of literature published up to 1 year after the pandemic declaration

Létourneau, Nicole; Luis, Mayara Alves; Kurbatfinski, Stefan; Ferrara, Hannah J.; Pohl, Carrie; Marabotti, Franciele; Hayden, K. Alix

doi:10.1016/j.eclinm.2022.101634

Cited by 21 publications

(28 citation statements)

References 75 publications

(472 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Since its emergence, SARS-CoV-2 has rapidly spread across the world and caused substantial mortality and long-term sequelae . Furthermore, as the COVID-19 pandemic progressed, the virus has transformed and negatively impacted children’s school life, mental health, and social development . This meta-analysis collected published data investigating the mRNA vaccines and indicated the associations between vaccination and lower risks of SARS-CoV-2 infections and COVID-19–related illnesses.…”

Section: Discussionmentioning

confidence: 93%

“…1,43 Furthermore, as the COVID-19 pandemic progressed, the virus has transformed and negatively impacted children's school life, mental health, and social development. [44][45][46] This meta-analysis collected published data investigating the mRNA vaccines and indicated the associations between vaccination and lower risks of SARS-CoV-2 infections and COVID-19-related illnesses. Although children tend to develop milder symptoms than adults due to COVID-19, 2 severe cases have still been identified.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years

et al. 2023

View full text Add to dashboard Cite

ImportanceEvidence of the efficacy and safety of messenger RNA (mRNA) COVID-19 vaccines in children aged 5 to 11 years has been emerging. Collecting these data will inform clinicians, families, and policy makers.ObjectiveTo evaluate the efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years in a systematic review and meta-analysis.Data SourcesPubMed and Embase databases were searched on September 29, 2022, without language restrictions.Study SelectionRandomized clinical trials and observational studies comparing vaccinated vs unvaccinated children aged 5 to 11 years and reporting efficacy or safety outcomes were included. Studies reporting safety outcomes in vaccinated children only (ie, no control group) were also included.Data Extraction and SynthesisTwo investigators independently extracted relevant data from each study. Odds ratios (ORs) for efficacy and safety outcomes and incidences of adverse events (AEs) following vaccination were synthesized using a random-effects model. This study followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses and Meta-analysis of Observational Studies in Epidemiology reporting guidelines.Main Outcomes and MeasuresThe primary outcome was SARS-CoV-2 infections with or without symptoms. The secondary outcomes included symptomatic SARS-CoV-2 infections, hospitalizations, and multisystem inflammatory syndrome in children. The incidences of each AE following vaccination were also evaluated.ResultsTwo randomized clinical trials and 15 observational studies involving 10 935 541 vaccinated children (median or mean age range, 8.0-9.5 years) and 2 635 251 unvaccinated children (median or mean age range, 7.0-9.5 years) were included. Two-dose mRNA COVID-19 vaccination compared with no vaccination was associated with lower risks of SARS-CoV-2 infections with or without symptoms (OR, 0.47; 95% CI, 0.35-0.64), symptomatic SARS-CoV-2 infections (OR, 0.53; 95% CI, 0.41-0.70), hospitalizations (OR, 0.32; 95% CI, 0.15-0.68), and multisystem inflammatory syndrome in children (OR, 0.05; 95% CI, 0.02-0.10). Two randomized clinical trials and 5 observational studies investigated AEs among vaccinated children. Most vaccinated children experienced at least 1 local AE following the first injection (32 494 of 55 959 [86.3%]) and second injection (28 135 of 46 447 [86.3%]). Vaccination was associated with a higher risk of any AEs compared with placebo (OR, 1.92; 95% CI, 1.26-2.91). The incidence of AEs that prevented normal daily activities was 8.8% (95% CI, 5.4%-14.2%) and that of myocarditis was estimated to be 1.8 per million (95% CI, 0.000%-0.001%) following the second injection.Conclusions and RelevanceIn this systematic review and meta-analysis, COVID-19 mRNA vaccines among children aged 5 to 11 years were associated with measures of efficacy in preventing SARS-CoV-2 infection and severe COVID-19–related illnesses. While most children developed local AEs, severe AEs were rare, and most of AEs resolved within several days. These data provide evidence for future recommendations.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Discussionmentioning

confidence: 99%

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In comparison with the reduction in total emergency department visits for any health reason, the findings reported in this study provide strong evidence for relative increases in attempted suicide, self-harm, and suicidal ideation during the COVID-19 pandemic. Commensurate with an accumulation of pandemic stressors, 1 , 2 , 4 , 5 , 8 , 9 there were decreases in access to various sources of support shown to prevent mental distress or mitigate its progression to severe outcomes. Together, these factors could have pushed children and adolescents, particularly girls and older adolescents, beyond their vulnerability thresholds.…”

Section: Discussionmentioning

confidence: 99%

“…During the pandemic, children and adolescents have had to endure repeated disruptions to schooling, social life, peer-group interactions, and extracurricular activities. Individual and family-level risk factors for paediatric mental distress have also increased during the pandemic, including increased screen time, 1 reduced physical activity, 2 and decreases in perceived connectedness to family and peers, 3 as well as increases in family violence, 4 parental depression and anxiety, 5 parental alcohol consumption, 6 parents losing jobs or facing disruptions, and caregiver death. 7 In population-based samples, paediatric depression and anxiety 8 and eating disorders 9 have also been estimated to have increased during the pandemic.…”

Section: Introductionmentioning

confidence: 99%

Comparison of paediatric emergency department visits for attempted suicide, self-harm, and suicidal ideation before and during the COVID-19 pandemic: a systematic review and meta-analysis

Madigan

Korczak

Vaillancourt

et al. 2023

The Lancet Psychiatry

View full text Add to dashboard Cite

“…Numerous etiological factors for psychopathology also appeared or were exacerbated during the pandemic, including increased screen time, closures and disruptions related to schooling, cancellation of extracurricular activities, increased loneliness, decreased physical activity, and lack of access to school mental health supports . Commensurate with these risk factors were considerable changes to the family milieu, which can have spillover effects on child and adolescent well-being, such as increases in parent depression and anxiety symptoms, family violence, job loss, and alcohol consumption . However, longitudinal cohort studies examining changes from before to during the pandemic have revealed a range of different findings: some studies reported that depression and anxiety symptoms have decreased or remained stable, while others showed various levels of increase .…”

Section: Introductionmentioning

confidence: 99%

Changes in Depression and Anxiety Among Children and Adolescents From Before to During the COVID-19 Pandemic

et al. 2023

View full text Add to dashboard Cite

ImportanceThere is a growing body of high-quality cohort-based research that has examined changes in child and adolescent mental health during the COVID-19 pandemic vs before the pandemic. Some studies have found that child and adolescent depression and anxiety symptoms have increased, while others have found these symptoms to have remained stable or decreased.ObjectiveTo synthesize the available longitudinal cohort-based research evidence to estimate the direction and magnitude of changes in depression and anxiety symptoms in children and adolescents assessed before and during the pandemic.Data SourcesMedline, Embase, and PsycInfo were searched for studies published between January 1, 2020, and May 17, 2022.Study SelectionIncluded studies reported on depression and/or anxiety symptoms, had cohort data comparing prepandemic to pandemic estimates, included a sample of children and/or adolescents younger than 19 years, and were published in English in a peer-reviewed journal.Data Extraction and SynthesisIn total, 53 longitudinal cohort studies from 12 countries with 87 study estimates representing 40 807 children and adolescents were included.Main Outcomes and MeasuresStandardized mean changes (SMC) in depression and anxiety symptoms from before to during the pandemic.ResultsThe analysis included 40 807 children and adolescents represented in pre–COVID-19 studies and 33 682 represented in during–COVID-19 studies. There was good evidence of an increase in depression symptoms (SMC, 0.26; 95% CI, 0.19 to 0.33). Changes in depression symptoms were most conclusive for study estimates among female individuals (SMC, 0.32; 95% CI, 0.21 to 0.42), study estimates with mid to high income (SMC, 0.35; 95% CI, 0.07 to 0.63), and study estimates sourced from North America (SMC, 0.25; 95% CI, 0.15 to 0.36) and Europe (SMC, 0.35; 95% CI, 0.17 to 0.53). There was strong evidence that anxiety symptoms increased slightly during the pandemic (SMC, 0.10; 95% CI, 0.04 to 0.16), and there was some evidence of an increase in study estimates with mid to high income.ConclusionsThis systematic review and meta-analysis of longitudinal studies including children and adolescents found an increase in depression symptoms during the COVID-19 pandemic, particularly among female individuals and those from relatively higher-income backgrounds.

show abstract

COVID-19 and family violence: A rapid review of literature published up to 1 year after the pandemic declaration

Cited by 21 publications

References 75 publications

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years

Comparison of paediatric emergency department visits for attempted suicide, self-harm, and suicidal ideation before and during the COVID-19 pandemic: a systematic review and meta-analysis

Changes in Depression and Anxiety Among Children and Adolescents From Before to During the COVID-19 Pandemic

Contact Info

Product

Resources

About